Ryman Healthcare Limited
RHCGF
$1.44
$0.22518.60%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.98% | 8.63% | 9.40% | 5.92% | 11.93% |
| Total Other Revenue | 0.03% | 5.52% | 43.89% | 39.31% | 18.20% |
| Total Revenue | 2.81% | 8.45% | 11.03% | 7.50% | 12.29% |
| Cost of Revenue | -10.00% | -5.06% | 18.93% | 15.15% | 48.02% |
| Gross Profit | 78.64% | 77.47% | -43.73% | -45.52% | -309.86% |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -11.97% | -7.14% | 18.25% | 14.49% | 60.43% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.11% | -5.18% | 18.89% | 15.11% | 48.65% |
| Operating Income | 60.77% | 58.62% | -110.29% | -109.96% | -650.38% |
| Income Before Tax | 10.83% | 5.94% | 42.89% | 38.35% | -3,452.60% |
| Income Tax Expenses | 367.71% | 382.40% | 228.12% | 224.04% | 36.64% |
| Earnings from Continuing Operations | -38.00% | -45.57% | -49.02% | -50.65% | -643.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.00% | -45.57% | -49.02% | -50.65% | -643.55% |
| EBIT | 60.77% | 58.62% | -110.29% | -109.96% | -650.38% |
| EBITDA | 67.97% | 66.22% | -45.39% | -47.12% | -550.46% |
| EPS Basic | -29.52% | -36.63% | -48.97% | -50.65% | -521.49% |
| Normalized Basic EPS | 10.38% | 5.64% | -1,113.33% | -1,025.00% | 40.96% |
| EPS Diluted | -29.52% | -36.54% | -49.45% | -51.01% | -521.49% |
| Normalized Diluted EPS | 10.38% | 5.64% | -1,113.33% | -1,025.00% | 40.96% |
| Average Basic Shares Outstanding | 6.56% | 6.56% | 0.00% | 0.00% | 29.10% |
| Average Diluted Shares Outstanding | 6.56% | 6.56% | 0.00% | 0.00% | 29.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |